{"title":"Assessing the Geographic Distribution of Community-Based Pharmacy Residency Programs in Areas of Health Care Need","authors":"Chardaé Whitner , Inas Mahdi , Aicha Ndiaye , Ruth Adeyemi , William Wei-Han Chen , Jingchuan Guo , Stacey Curtis","doi":"10.1016/j.ajpe.2025.101860","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>To evaluate the geographic distribution of American Society of Health-System Pharmacists Community-Based Pharmacy Residency programs in relation to federally designated areas of health care need and social vulnerability across the United States.</div></div><div><h3>Methods</h3><div>Community-Based Pharmacy Residency Program addresses were collected from September 2023 to September 2024 through a 3-phase approach: an initial Qualtrics survey of Residency Program Directors, review of program websites, and telephone call follow-up. The resulting 268 addresses (approximately 80% of US Community-Based Pharmacy Residency programs) were analyzed using ArcGIS Pro to assess their distribution relative to 3 federal metrics: Medically Underserved Areas (MUA) (score ≥ 62), Primary Care Health Professional Shortage Areas (P-HPSAs) (score ≥ 19), and the Centers for Disease Control and Prevention (CDC) Social Vulnerability Index (SVI).</div></div><div><h3>Results</h3><div>Of the 268 Community-Based Pharmacy Residency sites, 37.3% were in MUAs and 41.4% in P-HPSAs. Although 68.3% of programs were in areas of higher CDC SVI, only 2.6% were in the highest-vulnerability communities, indicating limited presence in areas of greatest need.</div></div><div><h3>Conclusion</h3><div>The expansion of Community-Based Pharmacy Residency programs in MUAs, P-HPSAs, and CDC SVIs could present a vital strategy to address health care disparities and improve access to pharmacist-led clinical services and health care.</div></div>","PeriodicalId":55530,"journal":{"name":"American Journal of Pharmaceutical Education","volume":"89 10","pages":"Article 101860"},"PeriodicalIF":3.5000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Pharmaceutical Education","FirstCategoryId":"95","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0002945925005054","RegionNum":4,"RegionCategory":"教育学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"EDUCATION, SCIENTIFIC DISCIPLINES","Score":null,"Total":0}
引用次数: 0
Abstract
Objective
To evaluate the geographic distribution of American Society of Health-System Pharmacists Community-Based Pharmacy Residency programs in relation to federally designated areas of health care need and social vulnerability across the United States.
Methods
Community-Based Pharmacy Residency Program addresses were collected from September 2023 to September 2024 through a 3-phase approach: an initial Qualtrics survey of Residency Program Directors, review of program websites, and telephone call follow-up. The resulting 268 addresses (approximately 80% of US Community-Based Pharmacy Residency programs) were analyzed using ArcGIS Pro to assess their distribution relative to 3 federal metrics: Medically Underserved Areas (MUA) (score ≥ 62), Primary Care Health Professional Shortage Areas (P-HPSAs) (score ≥ 19), and the Centers for Disease Control and Prevention (CDC) Social Vulnerability Index (SVI).
Results
Of the 268 Community-Based Pharmacy Residency sites, 37.3% were in MUAs and 41.4% in P-HPSAs. Although 68.3% of programs were in areas of higher CDC SVI, only 2.6% were in the highest-vulnerability communities, indicating limited presence in areas of greatest need.
Conclusion
The expansion of Community-Based Pharmacy Residency programs in MUAs, P-HPSAs, and CDC SVIs could present a vital strategy to address health care disparities and improve access to pharmacist-led clinical services and health care.
期刊介绍:
The Journal accepts unsolicited manuscripts that have not been published and are not under consideration for publication elsewhere. The Journal only considers material related to pharmaceutical education for publication. Authors must prepare manuscripts to conform to the Journal style (Author Instructions). All manuscripts are subject to peer review and approval by the editor prior to acceptance for publication. Reviewers are assigned by the editor with the advice of the editorial board as needed. Manuscripts are submitted and processed online (Submit a Manuscript) using Editorial Manager, an online manuscript tracking system that facilitates communication between the editorial office, editor, associate editors, reviewers, and authors.
After a manuscript is accepted, it is scheduled for publication in an upcoming issue of the Journal. All manuscripts are formatted and copyedited, and returned to the author for review and approval of the changes. Approximately 2 weeks prior to publication, the author receives an electronic proof of the article for final review and approval. Authors are not assessed page charges for publication.